Marcum Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$354K Buy
3,774
+46
+1% +$4.12K 0.03% 258
2024
Q4
$339K Buy
3,728
+282
+8% +$26.9K 0.03% 261
2024
Q3
$358K Buy
3,446
+57
+2% +$5.81K 0.03% 244
2024
Q2
$329K Buy
3,389
+201
+6% +$18.5K 0.03% 253
2024
Q1
$287K Buy
3,188
+64
+2% +$5.42K 0.03% 278
2023
Q4
$249K Sell
3,124
-35
-1% -$2.63K 0.03% 294
2023
Q3
$225K Buy
3,159
+157
+5% +$11.7K 0.03% 298
2023
Q2
$231K Buy
+3,002
New +$232K 0.03% 299

Other funds holding CL

Marcum Wealth's CL Position: Q1 2025 in Review

Marcum Wealth increased its Colgate-Palmolive (CL) stake by 1.2% in Q1 2025, buying an estimated $4.12K and bringing the position to 3,774 shares worth $354K. The position accounts for 0.03% of the portfolio, ranked #258.

Marcum Wealth first reported a position in CL in Q2 2023 and has held it in 8 quarters since. The position peaked at $358K in Q3 2024. 1,943 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Marcum Wealth held 3,774 shares of Colgate-Palmolive worth $354K as of Q1 2025.
  • Marcum Wealth bought 46 Colgate-Palmolive shares in Q1 2025, an estimated $4.12K.
  • Colgate-Palmolive made up 0.03% of Marcum Wealth's portfolio in Q1 2025, its #258 holding.
  • Marcum Wealth first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 8 quarters since.
  • Marcum Wealth's Colgate-Palmolive position peaked at $358K in Q3 2024.
  • 1,943 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Marcum Wealth's 13F filing for Q1 2025, filed 2 Apr 2025.